Psychopharmacological treatment for very young children: contexts and guidelines
- PMID: 18030077
- DOI: 10.1097/chi.0b013e3181570d9e
Psychopharmacological treatment for very young children: contexts and guidelines
Abstract
Systematic research and practice guidelines addressing preschool psychopharmacological treatment in very young children are limited, despite evidence of increasing clinical use of medications in this population. The Preschool Psychopharmacology Working Group (PPWG) was developed to review existing literature relevant to preschool psychopharmacology treatment and to develop treatment recommendations to guide clinicians considering psychopharmacological treatment in very young children. This article reviews the developmental considerations related to preschool psychopharmacological treatment, presents current evidence bases for specific disorders in early childhood, and describes the recommended algorithms for medication use. The purpose of this effort is to promote responsible treatment of young children, recognizing that this will sometimes involve the use of medications.
Similar articles
-
Psychopharmacology and preschoolers: a critical review of current conditions.Child Adolesc Psychiatr Clin N Am. 2009 Jul;18(3):753-71. doi: 10.1016/j.chc.2009.02.005. Child Adolesc Psychiatr Clin N Am. 2009. PMID: 19486849 Review.
-
Risperidone-to-methylphenidate switch reaction in children: three cases.J Psychopharmacol. 2007 Mar;21(2):216-9. doi: 10.1177/0269881107069466. J Psychopharmacol. 2007. PMID: 17329303
-
Review of pharmacotherapy options for the treatment of attention-deficit/hyperactivity disorder (ADHD) and ADHD-like symptoms in children and adolescents with developmental disorders.Dev Disabil Res Rev. 2010;16(3):273-82. doi: 10.1002/ddrr.120. Dev Disabil Res Rev. 2010. PMID: 20981766 Review.
-
Use of medication in children with psychiatric disorders.Community Pract. 2007 Nov;80(11):42, 44. Community Pract. 2007. PMID: 18064853 Review.
-
Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.Pediatrics. 2005 Jun;115(6):e749-57. doi: 10.1542/peds.2004-2560. Pediatrics. 2005. PMID: 15930203 Review.
Cited by
-
Risperidone or Aripiprazole Can Resolve Autism Core Signs and Symptoms in Young Children: Case Study.Children (Basel). 2021 Apr 22;8(5):318. doi: 10.3390/children8050318. Children (Basel). 2021. PMID: 33921933 Free PMC article.
-
Escitalopram in Preschool-Age Children Diagnosed with Obsessive Compulsive Disorder: A Case Report .Iran J Psychiatry. 2016 Jan;11(1):64-6. Iran J Psychiatry. 2016. PMID: 27252771 Free PMC article. No abstract available.
-
Effectiveness of Stimulant Medications on Disruptive Behavior and Mood Problems in Young Children.Clin Psychopharmacol Neurosci. 2020 Aug 31;18(3):402-411. doi: 10.9758/cpn.2020.18.3.402. Clin Psychopharmacol Neurosci. 2020. PMID: 32702219 Free PMC article.
-
Psychosocial treatment efficacy for disruptive behavior problems in very young children: a meta-analytic examination.J Am Acad Child Adolesc Psychiatry. 2013 Jan;52(1):26-36. doi: 10.1016/j.jaac.2012.10.001. Epub 2012 Dec 12. J Am Acad Child Adolesc Psychiatry. 2013. PMID: 23265631 Free PMC article.
-
Child and adolescent psychiatrists' reported monitoring behaviors for second-generation antipsychotics.J Child Adolesc Psychopharmacol. 2015 May;25(4):351-61. doi: 10.1089/cap.2014.0156. Epub 2015 Apr 28. J Child Adolesc Psychopharmacol. 2015. PMID: 25918843 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical